Cyclooxygenase-2 and gastric cancer

Cancer and Metastasis Reviews

Volumn 30, Issue 3-4, 2011, Pages 387-395

  Thiel, Alexandra ^a,b   Mrena, Johanna ^a,c   Ristimäki, Ari ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

Carcinogenesis; Celecoxib; Cyclooxygenase 2; Gastric cancer; Prostaglandin E 2

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ACETYLSALICYLIC ACID; CELECOXIB; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GASTRIN; GEFITINIB; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; GLYCOGEN SYNTHASE KINASE 3BETA; INTESTINAL TREFOIL FACTOR; METHYLNITROSOUREA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROBIOTIC AGENT; PROSTAGLANDIN E2; PROTEIN KINASE B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2; WNT PROTEIN;

ADENOMA; ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATROPHIC GASTRITIS; C57BL 6 MOUSE; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CARDIOVASCULAR RISK; CHRONIC GASTRITIS; COHORT ANALYSIS; DRUG MECHANISM; DYSPLASIA; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; EPITHELIUM CELL; GASTRITIS; GASTROINTESTINAL DYSPLASIA; GENE EXPRESSION; HELICOBACTER FELIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERPLASIA; IN VIVO STUDY; INTESTINE METAPLASIA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH TUMOR; STOMACH ULCER; SURVIVAL; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR MODEL; TUMOR PROMOTION; UMBILICAL VEIN ENDOTHELIAL CELL; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; STOMACH NEOPLASMS;

EID: 83855165726     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9312-1     Document Type: Article

References (95)

1. J Ferlay HR Shin F Bray D Forman C Mathers DM Parkin 2010 Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 International Journal of Cancer 127 12 2893 2917 10.1002/ijc.25516 1:CAS:528:DC%2BC3cXhtlWhs7fO
2. KD Crew AI Neugut 2006 Epidemiology of gastric cancer World Journal of Gastroenterology 12 3 354 362 16489633
3. K Shikata Y Doi K Yonemoto H Arima T Ninomiya M Kubo, et al. 2008 Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: The hisayama study American Journal of Epidemiology 168 12 1409 1415 18945691 10.1093/aje/kwn276
4. P Vogiatzi C Vindigni F Roviello A Renieri A Giordano 2007 Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis Journal of Cellular Physiology 211 2 287 295 17238139 10.1002/jcp.20982 1:CAS:528:DC%2BD2sXktVSrtr0%3D
5. M Yin Z Hu D Tan JA Ajani Q Wei 2009 Molecular epidemiology of genetic susceptibility to gastric cancer: Focus on single nucleotide polymorphisms in gastric carcinogenesis American Journal of Translational Research 1 1 44 54 19966937 1:CAS:528:DC%2BD1MXhtFejs7jO
6. A Greenhough HJ Smartt AE Moore HR Roberts AC Williams C Paraskeva, et al. 2009 The COX-2/PGE2 pathway: Key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 3 377 386 19136477 10.1093/carcin/bgp014 1:CAS:528:DC%2BD1MXivFSiuro%3D
7. DG Menter RL Schilsky RN DuBois 2010 Cyclooxygenase-2 and cancer treatment: Understanding the risk should be worth the reward Clinical Cancer Research 16 5 1384 1390 20179228 10.1158/1078-0432.CCR-09-0788 1:CAS:528:DC%2BC3cXisFSisrs%3D
8. MJ Thun MM Namboodiri EE Calle WD Flanders CW Heath Jr 1993 Aspirin use and risk of fatal cancer Cancer Research 53 6 1322 1327 8443812 1:CAS:528:DyaK3sXktl2qtLY%3D
9. DM Schreinemachers RB Everson 1994 Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 2 138 146 8172988 10.1097/00001648-199403000-00003 1:STN:280:DyaK2c3islWmsw%3D%3D
10. D Zaridze E Borisova D Maximovitch V Chkhikvadze 1999 Aspirin protects against gastric cancer: Results of a case-control study from Moscow, Russia International Journal of Cancer 82 4 473 476 10.1002/(SICI)1097-0215(19990812) 82:4<473::AID-IJC1>3.0.CO;2-K 1:CAS:528:DyaK1MXltVKqsbo%3D
11. MJ Langman KK Cheng EA Gilman RJ Lancashire 2000 Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database BMJ 320 7250 1642 1646 10856067 10.1136/bmj.320.7250.1642 1:STN:280:DC%2BD3czhsVejsQ%3D%3D
12. K Akre AM Ekstrom LB Signorello LE Hansson O Nyren 2001 Aspirin and risk for gastric cancer: A population-based case-control study in Sweden British Journal of Cancer 84 7 965 968 11286478 10.1054/bjoc.2001.1702 1:CAS:528:DC%2BD3MXktVejsr8%3D
13. CC Abnet ND Freedman F Kamangar MF Leitzmann AR Hollenbeck A Schatzkin 2009 Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: Results from a cohort study and a meta-analysis British Journal of Cancer 100 3 551 557 19156150 10.1038/sj.bjc.6604880 1:CAS:528: DC%2BD1MXhsFektr0%3D
14. A Ristimäki N Honkanen H Jänkälä P Sipponen M Härkönen 1997 Expression of cyclooxygenase-2 in human gastric carcinoma Cancer Research 57 7 1276 1280 9102213
15. K Saukkonen J Rintahaka A Sivula CJ Buskens BP Van Rees MC Rio, et al. 2003 Cyclooxygenase-2 and gastric carcinogenesis Acta Pathologica, Microbiologica, et Immunologica Scandinavica 111 10 915 925 14616542 10.1034/j.1600-0463.2003.1111001.x 1:CAS:528:DC%2BD3sXps12lsbw%3D
16. HY Lim HJ Joo JH Choi JW Yi MS Yang DY Cho, et al. 2000 Increased expression of cyclooxygenase-2 protein in human gastric carcinoma Clinical Cancer Research 6 2 519 525 10690533 1:CAS:528:DC%2BD3cXhs1aktr4%3D
17. K Saukkonen O Nieminen B van Rees S Vilkki M Härkönen M Juhola, et al. 2001 Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma Clinical Cancer Research 7 7 1923 1931 11448905 1:CAS:528:DC%2BD3MXlslaltbc%3D
18. BP van Rees K Saukkonen A Ristimaki W Polkowski GN Tytgat P Drillenburg, et al. 2002 Cyclooxygenase-2 expression during carcinogenesis in the human stomach The Journal of Pathology 196 2 171 179 11793368 10.1002/path.1033
19. PC Konturek SJ Konturek T Brzozowski 2009 Helicobacter pylori infection in gastric cancerogenesis Journal of Physiology and Pharmacology 60 3 3 21 19826177 1:CAS:528:DC%2BD1MXhsVeht7nJ
20. XL Guo LE Wang SY Du CL Fan L Li P Wang, et al. 2003 Association of cyclooxygenase-2 expression with hp-cagA infection in gastric cancer World Journal of Gastroenterology 9 2 246 249 12532440 1:CAS:528:DC%2BD3sXhsFynurs%3D
21. J Iwamoto Y Mizokami K Takahashi T Matsuoka Y Matsuzaki 2008 The effects of cyclooxygenase2-prostaglandin E2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells Helicobacter 13 3 174 182 18466392 10.1111/j.1523-5378.2008.00597.x 1:CAS:528:DC%2BD1cXns1altbc%3D
22. KM Sheehan K Sheahan DP O'Donoghue F MacSweeney RM Conroy DJ Fitzgerald, et al. 1999 The relationship between cyclooxygenase-2 expression and colorectal cancer Journal of the American Medical Association 282 13 1254 1257 10517428 10.1001/jama.282.13.1254 1:CAS:528:DyaK1MXmvVWhtbk%3D
23. CJ Buskens BP Van Rees A Sivula JB Reitsma C Haglund PJ Bosma, et al. 2002 Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus Gastroenterology 122 7 1800 1807 12055587 10.1053/gast.2002.33580 1:CAS:528:DC%2BD38Xlt12gs70%3D
24. A Ristimäki A Sivula J Lundin M Lundin T Salminen C Haglund, et al. 2002 Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Research 62 3 632 635 11830510
25. TL Erkinheimo H Lassus A Sivula S Sengupta H Furneaux T Hla, et al. 2003 Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma Cancer Research 63 22 7591 7594 14633672 1:CAS:528:DC%2BD3sXptFOls7w%3D
26. A Juuti J Louhimo S Nordling A Ristimaki C Haglund 2006 Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer Journal of Clinical Pathology 59 4 382 386 16467169 10.1136/jcp.2005.026831 1:CAS:528:DC%2BD28XktVajsL8%3D
27. J Mrena JP Wiksten A Thiel A Kokkola L Pohjola J Lundin, et al. 2005 Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR Clinical Cancer Research 11 20 7362 7368 16243808 10.1158/1078-0432.CCR-05-0764 1:CAS:528:DC%2BD2MXhtFartbrJ
28. H Murata S Kawano S Tsuji M Tsuji H Sawaoka Y Kimura, et al. 1999 Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma The American Journal of Gastroenterology 94 2 451 455 10022645 10.1111/j.1572-0241.1999.876-e.x 1:CAS:528:DyaK1MXhtlSjsLs%3D
29. H Yamamoto F Itoh H Fukushima Y Hinoda K Imai 1999 Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability International Journal of Cancer 84 4 400 403 10.1002/(SICI)1097- 0215(19990820)84:4<400::AID-IJC12>3.0.CO;2-S 1:CAS:528:DyaK1MXkvFans7g%3D
30. JH Chen TY Liu CW Wu CW Chi 2001 Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: Cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor development and progression Medical Hypotheses 57 4 503 505 11601879 10.1054/mehy.2001.1374 1:CAS:528: DC%2BD3MXoslalt7w%3D
31. TL Lee WK Leung JY Lau JH Tong EK Ng FK Chan, et al. 2001 Inverse association between cyclooxygenase-2 overexpression and microsatellite instability in gastric cancer Cancer Letters 168 2 133 140 11403917 10.1016/S0304-3835(01)00527-4 1:CAS:528:DC%2BD3MXktlWms7o%3D
32. WK Leung KF To YP Ng TL Lee JY Lau FK Chan, et al. 2001 Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer British Journal of Cancer 84 3 335 339 11161397 10.1054/bjoc.2000.1607 1:CAS:528:DC%2BD3MXitFCitLw%3D
33. YE Joo WT Oh JS Rew CS Park SK Choi SJ Kim 2002 Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis Digestion 66 4 222 229 12592098 10.1159/000068366 1:CAS:528:DC%2BD3sXitFaisL8%3D
34. YE Joo JS Rew YH Seo SK Choi YJ Kim CS Park, et al. 2003 Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer Journal of Clinical Gastroenterology 37 1 28 33 12811205 10.1097/00004836-200307000-00009 1:CAS:528: DC%2BD3sXks1yqsbg%3D
35. HX Li XM Chang ZJ Song SX He 2003 Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma World Journal of Gastroenterology 9 4 674 677 12679908 1:CAS:528:DC%2BD3sXjs1agsb8%3D
36. H Shi JM Xu NZ Hu HJ Xie 2003 Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma World Journal of Gastroenterology 9 7 1421 1426 12854133 1:CAS:528:DC%2BD3sXoslajtrg%3D
37. HG Yu JY Li YN Yang HS Luo JP Yu JJ Meier, et al. 2003 Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer Cancer Letters 195 1 43 51 12767510 10.1016/S0304-3835(03)00153-8 1:CAS:528:DC%2BD3sXktFWmsLc%3D
38. H Okano H Shinohara A Miyamoto K Takaori N Tanigawa 2004 Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome Clinical Cancer Research 10 20 6938 6945 15501972 10.1158/1078-0432.CCR-0731-03 1:CAS:528:DC%2BD2cXpslGltbk%3D
39. JJ Sung WK Leung MY Go KF To AS Cheng EK Ng, et al. 2000 Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions The American Journal of Pathology 157 3 729 735 10980112 10.1016/S0002-9440(10)64586-5 1:CAS:528:DC%2BD3cXmvFWqtrk%3D
40. A Rajnakova S Moochhala PM Goh S Ngoi 2001 Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer Cancer Letters 172 2 177 185 11566494 10.1016/S0304-3835(01)00645-0 1:CAS:528:DC%2BD3MXmvVKkurg%3D
41. A Tatsuguchi K Matsui Y Shinji K Gudis T Tsukui T Kishida, et al. 2004 Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue Human Pathology 35 4 488 495 15116331 10.1016/j.humpath. 2003.10.025 1:CAS:528:DC%2BD2cXjtVegt7Y%3D
42. J Mrena JP Wiksten A Kokkola S Nordling A Ristimaki C Haglund 2010 COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer Tumour Biology 31 1 1 7 20237896 10.1007/s13277-009-0001-4 1:CAS:528:DC%2BC3cXkt1KksA%3D%3D
43. RS Bresalier RS Sandler H Quan JA Bolognese B Oxenius K Horgan, et al. 2005 Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial The New England Journal of Medicine 352 11 1092 1102 15713943 10.1056/NEJMoa050493 1:CAS:528:DC%2BD2MXit1Kqu7o%3D
44. SD Solomon JJ McMurray MA Pfeffer J Wittes R Fowler P Finn, et al. 2005 Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention The New England Journal of Medicine 352 11 1071 1080 15713944 10.1056/NEJMoa050405 1:CAS:528:DC%2BD2MXit1Kqur4%3D
45. NA Nussmeier AA Whelton MT Brown RM Langford A Hoeft JL Parlow, et al. 2005 Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery The New England Journal of Medicine 352 11 1081 1091 15713945 10.1056/NEJMoa050330 1:CAS:528:DC%2BD2MXit1Kqu74%3D
46. LJ Marnett 2009 The COXIB experience: A look in the rearview mirror Annual Review of Pharmacology and Toxicology 49 265 290 18851701 10.1146/annurev.pharmtox.011008.145638 1:CAS:528:DC%2BD1MXisV2jsb4%3D
47. GS Feng JL Ma BC Wong L Zhang WD Liu KF Pan, et al. 2008 Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention World Journal of Gastroenterology 14 28 4535 4539 18680235 10.3748/wjg.14.4535 1:CAS:528:DC%2BD1cXhtlGgu7jJ
48. M Tendo M Yashiro K Nakazawa N Yamada T Sawada M Ohira, et al. 2006 A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells Cancer Letters 244 2 247 251 16448745 10.1016/j.canlet.2005.12.019 1:CAS:528:DC%2BD28XhtVGitrbK
49. MM Bertagnolli CJ Eagle AG Zauber M Redston A Breazna K Kim, et al. 2009 Five-year efficacy and safety analysis of the adenoma prevention with celecoxib trial Cancer Prevention Research 2 4 310 321 19336730 10.1158/1940-6207.CAPR-08- 0206 1:CAS:528:DC%2BC3cXptFKgurc%3D
50. H Yokozaki 2000 Molecular characteristics of eight gastric cancer cell lines established in japan Pathology International 50 10 767 777 11107048 10.1046/j.1440-1827.2000.01117.x 1:CAS:528:DC%2BD3cXos1Orsrs%3D
51. A Thiel M Heinonen J Rintahaka T Hallikainen A Hemmes DA Dixon, et al. 2006 Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells The Journal of Biological Chemistry 281 8 4564 4569 16371352 10.1074/jbc.M512722200 1:CAS:528:DC%2BD28Xhs1elu7w%3D
52. TS Yeh CW Wu KW Hsu WJ Liao MC Yang AF Li, et al. 2009 The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2 Cancer Research 69 12 5039 5048 19491270 10.1158/0008-5472.CAN- 08-4021 1:CAS:528:DC%2BD1MXnt1eqtbs%3D
53. T Hla K Neilson 1992 Human cyclooxygenase-2 cDNA Proceedings of the National Academy of Sciences of the United States of America 89 16 7384 7388 1380156 10.1073/pnas.89.16.7384 1:CAS:528:DyaK3sXktVajurg%3D
54. JW Lim H Kim KH Kim 2001 Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells Laboratory Investigation 81 3 349 360 11310828 10.1038/labinvest.3780243 1:CAS:528:DC%2BD3MXivVKqsLk%3D
55. D Subramaniam S Ramalingam R May BK Dieckgraefe DE Berg C Pothoulakis, et al. 2008 Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: Differential transcriptional and posttranscriptional mechanisms Gastroenterology 134 4 1070 1082 18395088 10.1053/j.gastro.2008.01.040 1:CAS:528: DC%2BD1cXls1Glsrk%3D
56. CM Brennan JA Steitz 2001 HuR and mRNA stability Cellular and Molecular Life Sciences : CMLS 58 2 266 277 11289308 10.1007/PL00000854 1:CAS:528:DC%2BD3MXivFOltL8%3D
57. H Oshima M Oshima K Inaba MM Taketo 2004 Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice The EMBO Journal 23 7 1669 1678 15014433 10.1038/sj.emboj.7600170 1:CAS:528: DC%2BD2cXivVGgsbg%3D
58. H Shen WH Sun QP Xue J Wu YL Cheng GX Ding, et al. 2006 Influences of helicobacter pylori on cyclooxygenase-2 expression and prostaglandinE2 synthesis in rat gastric epithelial cells in vitro Journal of Gastroenterology and Hepatology 21 4 754 758 16677165 10.1111/j.1440-1746.2006.04299.x
59. S Juttner T Cramer S Wessler A Walduck F Gao F Schmitz, et al. 2003 Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: Critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors Cellular Microbiology 5 11 821 834 14531897 10.1046/j.1462-5822.2003.00324.x
60. YJ Chang MS Wu JT Lin BS Sheu T Muta H Inoue, et al. 2004 Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-src-dependent nuclear factor-kappaB activation Molecular Pharmacology 66 6 1465 1477 15456896 10.1124/mol.104. 005199 1:CAS:528:DC%2BD2cXhtVOit7rJ
61. YJ Chang MS Wu JT Lin CC Chen 2005 Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation Journal of Immunology 175 12 8242 8252 1:CAS:528:DC%2BD2MXht12jt73J
62. Q Li N Liu B Shen L Zhou Y Wang Y Wang, et al. 2009 Helicobacter pylori enhances cyclooxygenase 2 expression via p38MAPK/ATF-2 signaling pathway in MKN45 cells Cancer Letters 278 1 97 103 19201083 10.1016/j.canlet.2008.12.032 1:CAS:528:DC%2BD1MXktFajs7s%3D
63. WK Wu CW Lee CH Cho D Fan K Wu J Yu, et al. 2010 MicroRNA dysregulation in gastric cancer: A new player enters the game Oncogene 29 43 5761 5771 20802530 10.1038/onc.2010.352 1:CAS:528:DC%2BC3cXhtVyqsL%2FO
64. A Strillacci C Griffoni P Sansone P Paterini G Piazzi G Lazzarini, et al. 2009 MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells Experimental Cell Research 315 8 1439 1447 19133256 10.1016/j.yexcr.2008.12.010 1:CAS:528:DC%2BD1MXkslyksrc%3D
65. HJ Wang HJ Ruan XJ He YY Ma XT Jiang YJ Xia, et al. 2010 MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion European Journal of Cancer 46 12 2295 2303 20712078 10.1016/j.ejca.2010.05.012 1:CAS:528:DC%2BC3cXpsFyisrk%3D
66. Hao, Y., Gu, X., Zhao, Y., Greene, S., Sha, W., Smoot, D., et al. (2011). Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila), 4(7), 1073-1083.
67. M Yan RM Rerko P Platzer D Dawson J Willis M Tong, et al. 2004 15-hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers Proceedings of the National Academy of Sciences of the United States of America 101 50 17468 17473 15574495 10.1073/pnas.0406142101 1:CAS:528:DC%2BD2MXhslOjtQ%3D%3D
68. Z Liu X Wang Y Lu S Han F Zhang H Zhai, et al. 2008 Expression of 15-PGDH is down-regulated by COX-2 in gastric cancer Carcinogenesis 29 1219 1227 18174234 10.1093/carcin/bgm297 1:CAS:528:DC%2BD1cXot1Wjtr8%3D
69. A Thiel A Ganesan J Mrena S Junnila A Nykanen A Hemmes, et al. 2009 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer Clinical Cancer Research 15 14 4572 4580 19584167 10.1158/1078-0432.CCR-08-2518 1:CAS:528:DC%2BD1MXosV2lt7g%3D
70. H Tatsuwaki T Tanigawa T Watanabe H Machida H Okazaki H Yamagami, et al. 2010 Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma Cancer Science 101 2 550 558 19917058 10.1111/j.1349-7006.2009.01390.x 1:CAS:528:DC%2BC3cXivFequrs%3D
71. M Tong Y Ding HH Tai 2006 Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells Carcinogenesis 27 11 2170 2179 16632868 10.1093/carcin/bgl053 1:CAS:528:DC%2BD28XhtFKltr3O
72. D Wang RN Dubois 2010 Eicosanoids and cancer Nature Reviews. Cancer 10 3 181 193 20168319 10.1038/nrc2809 1:CAS:528:DC%2BC3cXitFemsbs%3D
73. YG Fu JJ Sung KC Wu HP Wu J Yu M Chan, et al. 2005 Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants Cancer Letters 224 2 243 252 15914275 10.1016/j.canlet.2004.11.038 1:CAS:528: DC%2BD2MXks1Ggtrg%3D
74. L Yao F Liu L Hong L Sun S Liang K Wu, et al. 2011 The function and mechanism of COX-2 in angiogenesis of gastric cancer cells Journal of Experimental & Clinical Cancer Research 30 13 10.1186/1756-9966-30-13 1:CAS:528:DC%2BC3MXitFyhsLk%3D
75. YB Ding RH Shi JD Tong XY Li GX Zhang WM Xiao, et al. 2005 PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system Experimental Oncology 27 2 108 113 15995627 1:CAS:528:DC%2BD2MXpsVajsrs%3D
76. WH Sun F Zhu GS Chen H Su C Luo QS Zhao, et al. 2008 Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro Cancer Letters 263 2 302 311 18258354 10.1016/j.canlet.2008.01.012 1:CAS:528:DC%2BD1cXks12nsLk%3D
77. XL Yuan L Chen MX Li P Dong J Xue J Wang, et al. 2010 Elevated expression of Foxp3 in tumor-infiltrating treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner Clinical Immunology 134 3 277 288 19900843 10.1016/j.clim.2009.10.005 1:CAS:528:DC%2BC3cXitVOhurk%3D
78. H Oshima A Matsunaga T Fujimura T Tsukamoto MM Taketo M Oshima 2006 Carcinogenesis in mouse stomach by simultaneous activation of the wnt signaling and prostaglandin E2 pathway Gastroenterology 131 4 1086 1095 17030179 10.1053/j.gastro.2006.07.014 1:CAS:528:DC%2BD28XhtFyru7fJ
79. H Oshima H Itadani H Kotani MM Taketo M Oshima 2009 Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling Cancer Research 69 7 2729 2733 19318548 10.1158/0008-5472.CAN-08-4394 1:CAS:528:DC%2BD1MXjvVWju7k%3D
80. H Oshima K Oguma YC Du M Oshima 2009 Prostaglandin E2, wnt, and BMP in gastric tumor mouse models Cancer Science 100 10 1779 1785 19622104 10.1111/j.1349-7006.2009.01258.x 1:CAS:528:DC%2BD1MXht12qs7vP
81. M Oshima H Oshima A Matsunaga MM Taketo 2005 Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice Cancer Research 65 20 9147 9151 16230370 10.1158/0008-5472.CAN-05-1936 1:CAS:528:DC%2BD2MXhtFWmurfF
82. H Itadani H Oshima M Oshima H Kotani 2009 Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer BMC Genomics 10 615 20015407 10.1186/1471-2164-10-615
83. H Oshima BK Popivanova K Oguma D Kong TO Ishikawa M Oshima 2011 Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis Cancer Science 102 4 713 719 21205091 10.1111/j.1349-7006.2011.01847.x 1:CAS:528:DC%2BC3MXltFGjsbY%3D
84. H Oshima K Hioki BK Popivanova K Oguma N Van Rooijen TO Ishikawa, et al. 2011 Prostaglandin E 2 signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors Gastroenterology 140 2 596 607.e7 21070778 10.1053/j.gastro.2010.11.007 1:CAS:528:DC%2BC3MXhtlSksLw%3D
85. O Lefebvre MP Chenard R Masson J Linares A Dierich M LeMeur, et al. 1996 Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein Science 274 5285 259 262 8824193 10.1126/science.274.5285.259 1:CAS:528:DyaK28XmtlWltrY%3D
86. K Saukkonen C Tomasetto K Narko MC Rio A Ristimäki 2003 Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice Cancer Research 63 12 3032 3036 12810622 1:CAS:528:DC%2BD3sXks1eit7c%3D
87. Thiel, A., Narko, K., Heinonen, M., Hemmes, A., Tomasetto, C., Rio M. C., et al. (in press). Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice. International Journal of Cancer.
88. L Udd P Katajisto DJ Rossi A Lepisto AM Lahesmaa A Ylikorkala, et al. 2004 Suppression of peutz-jeghers polyposis by inhibition of cyclooxygenase-2 Gastroenterology 127 4 1030 1037 15480979 10.1053/j.gastro.2004.07.059 1:CAS:528:DC%2BD2cXpsVOitro%3D
89. N Kanda H Seno M Kawada T Sawabu Y Uenoyoma T Nakajima, et al. 2006 Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice American Journal of Physiology. Gastrointestinal and Liver Physiology 290 3 G519 G527 16254046 10.1152/ajpgi.00113.2005 1:CAS:528:DC%2BD28Xjt1Sksbc%3D
90. KT Nam KB Hahm SY Oh M Yeo SU Han B Ahn, et al. 2004 The selective cyclooxygenase-2 inhibitor nimesulide prevents helicobacter pylori-associated gastric cancer development in a mouse model Clinical Cancer Research 10 23 8105 8113 15585646 10.1158/1078-0432.CCR-04-0896 1:CAS:528:DC%2BD2cXhtVCrs7vK
91. WK Leung KC Wu CY Wong AS Cheng AK Ching AW Chan, et al. 2008 Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice Carcinogenesis 29 8 1648 1654 18611916 10.1093/carcin/bgn156 1:CAS:528:DC%2BD1cXhtVSis7jP
92. S Takasu T Tsukamoto XY Cao T Toyoda A Hirata H Ban, et al. 2008 Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea- treated K19-C2mE transgenic mice Cancer Science 99 12 2356 2364 19018769 10.1111/j.1349-7006.2008.00983.x 1:CAS:528:DC%2BD1MXisF2gsA%3D%3D
93. W Tian Y Zhao S Liu X Li 2010 Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer European Journal of Cancer Prevention 19 4 288 298 20386312 10.1097/CEJ.0b013e328339648c 1:CAS:528:DC%2BC3cXntVSgtbg%3D
94. WK Leung EK Ng FK Chan WY Chan KF Chan AC Auyeung, et al. 2006 Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial Clinical Cancer Research 12 15 4766 4772 16899628 10.1158/1078-0432.CCR-06-0693 1:CAS:528:DC%2BD28XnvVGksbw%3D
95. LJ Zhang SY Wang XH Huo ZL Zhu JK Chu JC Ma MW Wang J Yu, et al. 2009 Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions World Journal of Gastroenterology 15 22 2731 2738 19522023 10.3748/wjg.15.2731 1:CAS:528:DC%2BD1MXpsF2rtbs%3D